Mobile Site ›
Print Friendly View

Test ID: AGXMS    
AGXT Gene, Full Gene Analysis

Secondary ID A test code used for billing and in test definitions created prior to November 2011

89915

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Conditional

Useful For Suggests clinical disorders or settings where the test may be helpful

Confirming a diagnosis of primary hyperoxaluria type 1

 

Carrier testing for individuals with a family history of primary hyperoxaluria type 1 in the absence of known mutations in the family

Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.

See Hyperoxaluria Diagnostic Algorithm in Special Instructions.

Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test

Method Name A short description of the method used to perform the test

Polymerase Chain Reaction (PCR) Followed by DNA Sequence Analysis and Gene Dosage Analysis by Multiplex Ligation-Dependent Probe Amplification (MLPA)
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

AGXT Gene, Full Gene Analysis

Aliases Lists additional common names for a test, as an aid in searching

AGXT (Alanine-Glyoxylate Aminotransferase)
Alanine-Glyoxylate Aminotransferase (AGXT)
Hyperoxaluria
PH1 (Primary Hyperoxaluria Type 1)
Primary Hyperoxaluria
Primary Hyperoxaluria Type 1 (PH1)